Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT07695207

Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Wi…

The purpose of this study is to evaluate the efficacy and safety of SMZ1 tablets in combination with Ranibizumab compared with placebo in combination with Ranib…

South Korea266 participantsStarted 2025-09-15Updated 2026-07-10

Treatment: SMZ1, SMZ1 Placebo

Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Wi…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Wi…

All recent trials (1 shown)